Aspen Aerogels Inc (NYSE: ASPN) has reported earnings for its second fiscal quarter (ending June 30) of $0.22 versus a loss $-0.22 for the same period a year ago. This result exceeded the consensus estimate of $0.06 by $0.16. For the latest four quarters through June 30, E.P.S. were $0.00 compared to $-1.42 a year ago.
Recent Price Action
Aspen Aerogels Inc (NYSE: ASPN) stock suffered a large decline of -6.2% on 8/7/24. The stock closed at $18.50. Moreover, this decline was accompanied by unusually high trading volume at 176% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -8.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ASPN is expected to be Value Creation neutral.
Aspen Aerogels has a current Value Trend Rating of B (Positive). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Aspen Aerogels has a poor Appreciation Score of 27 but a very high Power Rating of 100, with the Positive Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment